During the progression of colon cancer, compromised energy production in tumor cells facilitates the consumption of NK cell polyamines by these cells, which inhibits cMyc in NK cells and disrupts their glycolysis, ultimately diminishing their cytotoxic ability (64). Here, MYC is linked to neoplasm.